Compounds, particularly compounds having activity as modulators of cadherin-mediated cell adhesion having the following structure:
or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof,
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, A, X, Y, Z, m and n are as defined herein. Methods associated with preparation and use of the same, as well as pharmaceutical compositions containing the same, are also disclosed.